Abrdn Healthcare Investors (HQH) — Financial statements
Income statement, balance sheet, and cash flow for Abrdn Healthcare Investors — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 100↑826.8% | 11↑4.6% | 10↑24.4% | 8↑27.6% | 6 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 100↑826.8% | 11↑4.6% | 10↑24.4% | 8↑27.6% | 6 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 1↓89.5% | 11↓4.7% | 11↓3.9% | 12↓6.1% | 13 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 0.06 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 1↓89.6% | 11↓4.2% | 11↓3.9% | 12↓6.1% | 13 | |
| Other Expenses | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 1↓89.1% | 11↓4.2% | 11↓3.9% | 12↓6.1% | 13 | |
| Total Costs & Expenses | 1↓89.1% | 11↓4.2% | 11↓3.9% | 12↓6.1% | 13 | |
| Operating Results | ||||||
| Operating Income | 99↑44869.1% | -0.22↑81.4% | -1↑67.7% | -4↑41.1% | -6 | |
| Depreciation & Amortization | 0.00↓100.0% | 0.22↓81.4% | 1↓67.7% | 4↓41.1% | 6 | |
| EBITDA | 99 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBIT | 99↑44869.1% | -0.22↑81.4% | -1↑67.7% | -4↑41.1% | -6 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓50.4% | 2↑225.6% | 0.62↑452.0% | 0.11 | 0.00 | |
| Interest Income | 1↓50.4% | 2↑225.6% | 0.62↑452.0% | 0.11 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 0.00↓100.0% | 185↑221.9% | 58↑130.2% | -191↓218.1% | 161 | |
| Income Before Tax | 99↓46.7% | 185↑228.3% | 56↑129.0% | -194↓225.2% | 155 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 99↓46.7% | 185↑228.3% | 56↑129.0% | -194↓225.2% | 155 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 99↓46.7% | 185↑228.3% | 56↑129.0% | -194↓225.2% | 155 | |
| Bottom-Line Net Income | 99↓46.7% | 185↑228.3% | 56↑129.0% | -194↓225.2% | 155 | |
| EPS (Basic) | 1.84↓48.2% | 3.55↑211.4% | 1.14↑127.8% | -4.10↓217.5% | 3.49 | |
| EPS (Diluted) | 1.84↓48.2% | 3.55↑211.4% | 1.14↑127.8% | -4.10↓217.5% | 3.49 | |
| Weighted Average Shares | 54↑2.9% | 52↑5.4% | 49↑4.4% | 47↑4.2% | 45 | |
| Weighted Average Diluted Shares | 54↑2.9% | 52↑5.4% | 49↑4.4% | 47↑4.2% | 45 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.